If we look at the chart, we can see that after breaking above the important $10 resistance level, the price sharply rose by 400%.
However, after initially surpassing $40, INJ entered a consolidation phase.
Upon examining the weekly chart, it becomes evident that rallies above $40 were met with selling pressure.
Additionally, yesterday, following a new attempt to exceed $40, the price experienced a significant drop. In my view, these are all signs of a potential reversal.
Technically, as previously mentioned, the $40 zone acts as a strong resistance while $30 serves as a clearly defined support level.
A breach below this support could drive the price down to the next support level at $25. However, given the prolonged distribution around the $40 peak, I wouldn't be surprised to see Injective fall to $20 in the long run.
🎯 Want More Trading Ideas?
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
🎯 Want More Trading Ideas?
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
